http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815955-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8339f73f47970072fe8cc5ea95ceeb69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f173c417d36f9de8bf608bca134e266d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee049eb010ac50e6c052527219aa0f66
publicationDate 2014-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8815955-B2
titleOfInvention Method of treating ocular disorders
abstract A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related macular degeneration (AMD).
priorityDate 2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007082064-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226481204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129116523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409391

Total number of triples: 43.